Skip to content
AnalystLens
Back to MRNACash Flow

Moderna, Inc. Share-Based Compensation 2016-2026 | MRNA

Annual FY2016–FY2025 · quarterly through Q1 FY2026

Latest annual · FY2025

$483.0M

+12.6%YoY vs FY2024Source: 10-KFY2025

From $39.4M in FY2016 to $483.0M in FY2025: 12.3× in 9 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$104M−9.6%Not reportedNot reportedNot reported
FY25$115M+13.9%$130M+16.1%$125M+11.6%$113M+8.7%
FY24$101M+34.7%$112M+51.4%$112M+45.5%$104M+31.6%
FY23$75M+70.5%$74M+48.0%$77M+10.0%$79M+27.4%
FY22$44M+46.7%$50M+42.9%$70M+75.0%$62M+67.6%
Share22%25%27%26%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionGrowing
CAGR

+39.0%

FY2020
$93.0M
FY2025
$483.0M

5 years selected · on the chart

01—History

Share-Based Compensation History

Year-over-year comparison from 10-K annual reports

  10. $483.0M
YoY changeLargest recent move+81.2%in FY18Latest +12.6%

02—Ledger

Share-Based Compensation, period by period

PeriodValueChangeSource
FY2025$483.0M+12.6%10-K
FY2024$429.0M+40.7%10-K
FY2023$305.0M+35.0%10-K
FY2022$226.0M+59.2%10-K
FY2021$142.0M+52.7%10-K
FY2020$93.0M+14.8%10-K
FY2019$81.0M+11.6%10-K
FY2018$72.6M+81.2%10-K
FY2017$40.1M+1.8%10-K
FY2016$39.4M—10-K

03—Questions

What is share-based compensation?

Share-based compensation is the non-cash expense of stock options, restricted stock units, and other equity awards granted to employees.

What is Moderna, Inc.'s current share-based compensation?

Moderna, Inc. (MRNA) annual share-based compensation for 2025 was $483.0M, a 12.59% increase from 2024. Moderna, Inc. share-based compensation for the quarter ending March 31, 2026 was $104.0M.

What was Moderna, Inc.'s share-based compensation in 2024?

Moderna, Inc. annual share-based compensation for 2024 was $429.0M, a 40.66% increase from 2023.

What was Moderna, Inc.'s share-based compensation in 2023?

Moderna, Inc. annual share-based compensation for 2023 was $305.0M, a 34.96% increase from 2022.

What is Moderna, Inc.'s 5-year share-based compensation CAGR?

Moderna, Inc. share-based compensation grew at a compound annual growth rate (CAGR) of 39.02% from FY2020 to FY2025, going from $93.0M to $483.0M over 5 years.

Company
Moderna, Inc.
Ticker
MRNA
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
View company profile →